Letter by furlan regarding "critique of closure or medical therapy for cryptogenic stroke with patent foramen ovale: The hole truth?"

Stroke

Volumn 44, Issue 2, 2013, Pages

  Furlan, Anthony J ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN CORTEX; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COHORT ANALYSIS; DEVICE APPROVAL; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; LETTER; MEDICAID; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARADOXICAL EMBOLISM; PATENT FORAMEN OVALE; PRIORITY JOURNAL; REIMBURSEMENT; SEPTAL OCCLUDER; SHUNTING; TRANSIENT ISCHEMIC ATTACK;

FORAMEN OVALE, PATENT; HUMANS; STROKE;

EID: 84872976230     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.678755     Document Type: Letter

References (5)

1. Thaler DE, Wahl A. Critique of closure or medical therapy for cryptogenic stroke with patent foramen ovale: the hole truth? Stroke. 2012; 44:e10.
2. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, et al. CLOSURE I Investigators. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366:991-999.
3. Taggart NW, Dearani JA, Hagler DJ. Late erosion of an Amplatzer septal occluder device 6 years after placement. J Thorac Cardiovasc Surg. 2011;142:221-222.
4. Wahl A, Jüni P, Mono ML, Kalesan B, Praz F, Geister L, et al. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Circulation. 2012;125:803-812.
5. Kitsios GD, Dahabreh IJ, Abu Dabrh AM, Thaler DE, Kent DM. Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence. Stroke. 2012;43:422-431.